CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2022; 06(02): 131-140
DOI: 10.1055/s-0041-1734374
Review Article

Challenges in Image-Guided Drainage of Infected Pleural Collections: A Review

Ashu S. Bhalla
1   Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, India
,
Manisha Jana
1   Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, India
,
1   Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, India
,
Swish K. Singh
1   Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, India
,
Irshad Banday
1   Department of Radiodiagnosis, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, Delhi, India
› Author Affiliations

Abstract

Infected pleural fluid collections (IPFCs) commonly occur as a part of bacterial, fungal, or tubercular pneumonia or due to involvement of pleura through hematogenous route. Management requires early initiation of therapeutic drugs, as well as complete drainage of the fluid, to relieve patients' symptoms and prevent pleural fibrosis. Image-guided drainage plays an important role in achieving these goals and improving outcomes. Intrapleural fibrinolytic therapy (IPFT) is also a vital component of the management. The concepts of image-guided drainage procedures, IPFT, and nonexpanding lung are discussed in this review.

Supplementary Material



Publication History

Article published online:
12 October 2021

© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Light RW. Pleural Diseases. 6th ed. India: Wolters Kluwer 2019
  • 2 Scarci M, Abah U, Solli P. et al. EACTS expert consensus statement for surgical management of pleural empyema. Eur J Cardiothorac Surg 2015; 48 (05) 642-653
  • 3 Zahid I, Routledge T, Billè A, Scarci M. What is the best treatment of postpneumonectomy empyema?. Interact Cardiovasc Thorac Surg 2011; 12 (02) 260-264
  • 4 Balfour-Lynn IM, Abrahamson E, Cohen G. et al. Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005; 60 (Suppl. 01) i1-i21
  • 5 Davies HE, Davies RJ, Davies CW, Group BPDG. BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii41-ii53
  • 6 Shen KR, Bribriesco A, Crabtree T. et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 2017; 153 (06) e129-e146
  • 7 Colice GL, Curtis A, Deslauriers J. et al. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest 2000; 118 (04) 1158-1171
  • 8 Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108 (02) 299-301
  • 9 Pine JR, Hollman JL. Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 1983; 84 (01) 109-111
  • 10 Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005; 128 (04) 2732-2738
  • 11 El AA Solh, Alhajjhasan A, Ramadan FH, Pineda LA. A comparative study of community- and nursing home-acquired empyema thoracis. J Am Geriatr Soc 2007; 55 (11) 1847-1852
  • 12 Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174 (07) 817-823
  • 13 Lin YC, Chen HJ, Liu YH, Shih CM, Hsu WH, Tu CY. A 30-month experience of thoracic empyema in a tertiary hospital: emphasis on differing bacteriology and outcome between the medical intensive care unit (MICU) and medical ward. South Med J 2008; 101 (05) 484-489
  • 14 Ibitoye BO, Idowu BM, Ogunrombi AB, Afolabi BI. Ultrasonographic quantification of pleural effusion: comparison of four formulae. Ultrasonography 2018; 37 (03) 254-260
  • 15 Moy MP, Levsky JM, Berko NS, Godelman A, Jain VR, Haramati LB. A new, simple method for estimating pleural effusion size on CT scans. Chest 2013; 143 (04) 1054-1059
  • 16 Ahmed AE, Yacoub TE. Empyema thoracis. Clin Med Insights Circ Respir Pulm Med 2010; 4: 1-8
  • 17 Naranje P, Guleria R. Imaging of infections of pleura and chest wall. In: Bhalla AS, Jana M, eds. Clinicoradiological Series: Imaging of Chest Infections. Delhi, India: JP Brothers Medical Publishers 2018: 385-404
  • 18 Subotic D, Lardinois D, Hojski A. Minimally invasive thoracic surgery for empyema. Breathe (Sheff 2018; 14 (04) 302-310
  • 19 Andrews NC, Parker EF, Shaw RR, Wilson J, Webb WR. Management of nontuberculous empyema: a statement of the subcommittee on surgery. Am Rev Respir Dis 1962 85: 935-936
  • 20 Heffner JE, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg 1995; 130 (04) 433-438
  • 21 Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991; 99 (05) 1162-1165
  • 22 Corso RM, Agnoletti V, Piraccini E, Lupi C, Gambale G. Wire-guided chest tube placement in the intensive care unit. Anaesth Intensive Care 2012; 40 (06) 1071-1072
  • 23 Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160 (5, pt 1) 1682-1687
  • 24 Maskell NA, Davies CW, Nunn AJ. et al. First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352 (09) 865-874
  • 25 Rahman NM, Maskell NA, West A. et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365 (06) 518-526
  • 26 Rahman NM, Maskell NA, Davies CW. et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010; 137 (03) 536-543
  • 27 Havelock T, Teoh R, Laws D, Gleeson F, Group BPDG. BTS Pleural Disease Guideline Group. Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii61-ii76
  • 28 Hooper CE, Edey AJ, Wallis A. et al. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J 2015; 46 (02) 456-463
  • 29 Skeete DA, Rutherford EJ, Schlidt SA, Abrams JE, Parker LA, Rich PB. Intrapleural tissue plasminogen activator for complicated pleural effusions. J Trauma 2004; 57 (06) 1178-1183
  • 30 Thommi G, Nair CK, Aronow WS, Shehan C, Meyers P, McLeay M. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema. Am J Ther 2007; 14 (04) 341-345
  • 31 Heimes J, Copeland H, Lulla A. et al. The use of thrombolytics in the management of complex pleural fluid collections. J Thorac Dis 2017; 9 (05) 1310-1316
  • 32 Popowicz N, Bintcliffe O, De Fonseka D. et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. the alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc 2017; 14 (06) 929-936
  • 33 Redden MD, Chin TY, van Driel ML. Surgical versus non-surgical management for pleural empyema. Cochrane Database Syst Rev 2017; 3: CD010651
  • 34 Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2019; 2019 (10) CD002312
  • 35 Jester I, Nijran A, Singh M, Parikh DH. Surgical management of bronchopleural fistula in pediatric empyema and necrotizing pneumonia: efficacy of the serratus anterior muscle digitation flap. J Pediatr Surg 2012; 47 (07) 1358-1362
  • 36 Pierrepoint MJ, Evans A, Morris SJ, Harrison SK, Doull IJ. Pigtail catheter drain in the treatment of empyema thoracis. Arch Dis Child 2002; 87 (04) 331-332
  • 37 Thomson AH, Hull J, Kumar MR, Wallis C, Balfour IM Lynn. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57 (04) 343-347
  • 38 Petel D, Li P, Emil S. Percutaneous pigtail catheter versus tube thoracostomy for pediatric empyema: A comparison of outcomes. Surgery 2013; 154 (04) 655-660 discussion 660–661
  • 39 Lewis MR, Micic TA, Doull IJM, Evans A. Real-time ultrasound-guided pigtail catheter chest drain for complicated parapneumonic effusion and empyema in children - 16-year, single-centre experience of radiologically placed drains. Pediatr Radiol 2018; 48 (10) 1410-1416